{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Round Lake",
      "state": "IL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {
        "application_number": [
          "NDA018609"
        ],
        "brand_name": [
          "HEPARIN SODIUM IN SODIUM CHLORIDE"
        ],
        "generic_name": [
          "HEPARIN SODIUM"
        ],
        "manufacturer_name": [
          "Baxter Healthcare Corporation"
        ],
        "product_ndc": [
          "0338-0424",
          "0338-0431",
          "0338-0433",
          "0338-0428"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "HEPARIN SODIUM"
        ],
        "rxcui": [
          "1658690",
          "1658692"
        ],
        "spl_id": [
          "d28ff87a-c535-49db-ba0c-48080149936b"
        ],
        "spl_set_id": [
          "0d929726-76c3-48fc-b4e7-fd06409f9fb3"
        ],
        "package_ndc": [
          "0338-0431-03",
          "0338-0433-04",
          "0338-0424-18",
          "0338-0428-12"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "ZZ45AB24CA"
        ]
      },
      "product_type": "Drugs",
      "event_id": "95102",
      "recalling_firm": "Baxter Healthcare Corporation",
      "address_1": "25212 W Il Route 120",
      "address_2": "",
      "postal_code": "60073-9799",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0649-2024",
      "product_description": "Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA,  NDC 0338-0433-04",
      "product_quantity": "44,208 containers",
      "reason_for_recall": "Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.",
      "recall_initiation_date": "20240801",
      "center_classification_date": "20240830",
      "report_date": "20240911",
      "code_info": "Lot # N008235, Exp 8/31/2024",
      "more_code_info": ""
    }
  ]
}